Back to CITIGROUP INC CITIGROUP INC

SRPTSRPT
7 quarters

Position history for CITIGROUP INCCITIGROUP INC's holdings in SAREPTA THERAPEUTICS INC

CITIGROUP INC holds 1.2M shares of SRPT (SAREPTA THERAPEUTICS INC), worth $20.8M as of 2026-Q2. The position was increased (+0.6% shares). SRPT represents 0.0% of CITIGROUP INC's portfolio.

Current Value

$20.8M

Current Shares

1.2M

Total Value Change

+$11.7M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+0.6%
$20.8M0.0%$17.97
29
2026-Q1
Increased
1.1M
+0.1%
$25M0.0%$15.87
29
2025-Q4
Increased
1.1M
+12.5%
$24.7M0.0%$21.49
32
2025-Q3
Increased
1M
+384.5%
$19.6M0.0%$18.82
46
2025-Q2
Decreased
210,320
-45.2%
$3.6M0.0%$17.11
0
2025-Q1
Increased
383,827
+418.0%
$24.5M0.0%$70.41
46
2024-Q4
New
74,095
-
$9M0.0%$121.19
38

Other major holders of SRPT: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., Janus Henderson Group Ltd., BlackRock, Inc., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used